Gabapentin is generally considered safe when prescribed for its approved uses and taken as directed, but it carries real risks that depend heavily on who is taking it and what other medications are involved. It is FDA-approved for two conditions: nerve pain after shingles (postherpetic neuralgia) in adults and as an add-on treatment for partial seizures in people aged 3 and older. Most people tolerate it without serious problems, but specific combinations and health conditions can make it genuinely dangerous.
Common Side Effects
The side effects most people experience are related to the nervous system. In clinical trials, about 21% of participants reported drowsiness and 17% reported dizziness. Swelling in the hands or feet occurs in 1% to 10% of users. These effects tend to be most noticeable when starting the medication or increasing the dose, and they often lessen over time. For many people, drowsiness is the main complaint and the reason they stop taking it.
The Opioid Combination Risk
The most serious safety concern with gabapentin involves taking it alongside opioid painkillers. Research from the Ontario Drug Policy Research Network found that the odds of an opioid-related death were 49% higher among people recently exposed to both gabapentin and opioids compared to those taking opioids alone. At moderate to high doses of gabapentin, that risk climbed to roughly 60%. At very high doses, the odds of opioid-related death nearly doubled.
In 2019, the FDA issued a formal warning about serious breathing difficulties in patients using gabapentin who have respiratory risk factors. Those risk factors include concurrent use of opioids or other drugs that slow the central nervous system, lung conditions like COPD, and older age. Gabapentin on its own rarely causes respiratory depression, but layered on top of other sedating substances, it can suppress breathing enough to be life-threatening.
Safety Concerns for Older Adults
Gabapentin poses particular risks for people over 65. Studies tracking new gabapentin users against non-users found that within the first year, gabapentin users were roughly 55% more likely to show signs of cognitive decline on standard dementia screening tools, and nearly twice as likely to show decline on more detailed cognitive assessments. By the second year, the cognitive effects were less clear statistically, but fall risk became more pronounced. Gabapentin users had about 2.5 times the odds of experiencing falls by the two-year mark compared to non-users.
Fall risk also shows up in surgical settings. In one study of postoperative patients who fell, 18.1% had received gabapentin or a related drug, compared to only 9.9% of those who didn’t fall. For older adults already at risk of falls or cognitive problems, these numbers matter.
Kidney Function and Dosing
Your kidneys are responsible for clearing gabapentin from your body. Unlike many medications that are processed by the liver, gabapentin passes through the kidneys essentially unchanged. This means that if your kidneys aren’t working well, the drug builds up in your system, intensifying side effects like drowsiness, dizziness, and coordination problems.
People with reduced kidney function need significantly lower doses. Someone with moderately impaired kidneys might take half the standard dose, while someone with severe impairment might take a quarter or less. If you have chronic kidney disease, your prescriber should be adjusting the dose based on how well your kidneys filter, and that filtering ability can change over time.
Off-Label Prescribing
A large portion of gabapentin prescriptions are for conditions it was never formally approved to treat. These include chronic low back pain, migraines, bipolar disorder, anxiety, alcohol withdrawal, hot flashes, and restless leg syndrome. The evidence supporting many of these uses is thin. Much of the early enthusiasm came from case reports and uncontrolled studies rather than rigorous clinical trials. A Cochrane review noted that despite widespread use for chronic pain, surprisingly few trials actually demonstrated that gabapentin was effective for it.
This matters for safety because the risk-benefit calculation changes when the benefit side is uncertain. A drug’s side effects and risks are easier to accept when there’s strong evidence it works for your condition. When the evidence is weak, you’re taking on the same risks with less guaranteed payoff. If you’re taking gabapentin for an off-label use, it’s worth understanding that the strength of evidence varies considerably depending on the condition.
Pregnancy and Breastfeeding
Gabapentin’s safety during pregnancy is not well established. The FDA labels it as potentially harmful to fetal development, with the actual risk classified as unknown. Animal studies have raised concerns, but human data remains limited. Gabapentin also passes into breast milk, which raises questions about exposure to nursing infants. For women who take gabapentin for seizure control, stopping the medication carries its own serious risks, so this is a situation that requires weighing competing dangers rather than a simple yes-or-no answer.
How Gabapentin Works (and What We Don’t Know)
Despite decades of use, scientists still don’t fully understand how gabapentin produces its effects. Its name suggests a connection to GABA, a brain chemical that calms nerve activity, but gabapentin doesn’t actually interact with the GABA system. Lab studies show it binds to a specific part of calcium channels on nerve cells, which likely reduces the release of chemical signals involved in pain and seizure activity. But the FDA prescribing information itself states that the relationship between this binding and the drug’s therapeutic effects “is unknown.” This isn’t unusual for older medications, but it does mean that predicting exactly how the drug will behave in every patient remains imperfect.
What Makes Gabapentin Riskier
Gabapentin’s safety profile is best understood as a spectrum. For a younger adult with normal kidney function, no respiratory issues, and no other sedating medications, it is a relatively low-risk drug with manageable side effects. The risk climbs meaningfully when you add any of the following:
- Opioid use: the single biggest risk multiplier, associated with up to a 60% increase in overdose death
- Age over 65: higher rates of falls, cognitive effects, and respiratory sensitivity
- Kidney disease: slower drug clearance leads to accumulation and stronger side effects
- Lung conditions like COPD: breathing can be further suppressed
- Other sedating drugs: benzodiazepines, sleep aids, and muscle relaxants compound the drowsiness and respiratory risk
If none of those apply to you, gabapentin is one of the safer options in its class. If several apply, the risk profile changes substantially, and lower doses or alternative treatments may be worth discussing with your prescriber.